Multidrug Resistant Tuberculosis (MDR-TB)

G.B. Migliori, C. Lange

Source: CME Online 2010
Number: 7
Disease area: Respiratory infections

CME test or case report

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G.B. Migliori, C. Lange. Multidrug Resistant Tuberculosis (MDR-TB). CME Online 2010

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of 123 Cases with MDR TB (Multidrug Resistant Tuberculosis) Treatment
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Prevalence of Multidrug Resistant Tuberculosis among TB Patients in Malaysia.
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021

Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Analysis of multidrug-resistant tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013

Linezolid in the treatment of patients with MDR TB and XDR TB
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Multidrug-resistant tuberculosis (MDR-TB)
Source: Breathe 2010; 6: 283
Year: 2010

Management of MDR tuberculosis
Source: Short video discussion 2021
Year: 2021

Multidrug resistant pulmonary TB: Characteristics of drug resistance profiles of MBT in Ukraine
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011

Multidrug resistant tuberculosis in non HIV patients
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Multi-drug resistance tuberculosis in Greece
Source: Eur Respir J 2003; 22: Suppl. 45, 344s
Year: 2003

Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016

Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012


Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014